ABOUT AZELAPRAG WIKIPEDIA

The biotech sought to bear this mechanism out in STRIDES, a mid-phase, randomized, double-blinded and placebo-managed trial that evaluated the efficacy and basic safety of azelaprag—with and without having Eli Lilly’s blockbuster incretin procedure tirzepatide—in over two hundred persons with obesity.For MASH builders, a race for funds: Akero